Perrigo Company PLC
PRGO13.420USD
+0.505+3.91%
Cierre 11/26, 16:00（ET）Cotizaciones retrasadas 15 min
1.85BCap. mercado
PérdidaP/E TTM
Más Datos de Perrigo Company PLC Compañía
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Información de Perrigo Company PLC
Símbolo de cotizaciónPRGO
Nombre de la empresaPerrigo Company PLC
Fecha de salida a bolsaDec 17, 1991
Director ejecutivoMr. Patrick Lockwood-Taylor
Número de empleados8379
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 17
DirecciónThe Sharp Building
CiudadDUBLIN
Bolsa de valoresNYSE Consolidated
PaísIreland
Código postalD02 TY74
Teléfono3532696738451
Sitio Webhttps://www.perrigo.com/
Símbolo de cotizaciónPRGO
Fecha de salida a bolsaDec 17, 1991
Director ejecutivoMr. Patrick Lockwood-Taylor
Ejecutivos de Perrigo Company PLC
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
Ms. Adriana (Andi) Karaboutis
Ms. Adriana (Andi) Karaboutis
Independent Director
Independent Director
27.63K
+22.91%
Mr. Orlando D. Ashford
Mr. Orlando D. Ashford
Independent Chairman of the Board
Independent Chairman of the Board
22.17K
+40.91%
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Independent Director
Independent Director
10.56K
+95.21%
Ms. Julia M. Brown
Ms. Julia M. Brown
Independent Director
Independent Director
8.03K
+178.57%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
Otro
299.20M
28.33%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
610.90M
57.83%
Europe
421.70M
39.92%
All other countries
23.70M
2.24%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
Otro
299.20M
28.33%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
Otro
58.46%
Accionistas
Accionistas
Proporción
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
Otro
58.46%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
63.82%
Investment Advisor/Hedge Fund
37.56%
Hedge Fund
5.32%
Research Firm
2.06%
Pension Fund
1.58%
Sovereign Wealth Fund
1.12%
Bank and Trust
0.47%
Individual Investor
0.45%
Insurance Company
0.06%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
771
148.06M
107.58%
-20.94M
2025Q2
791
145.85M
106.01%
-21.49M
2025Q1
812
142.34M
103.61%
-25.15M
2024Q4
806
140.28M
102.80%
-22.73M
2024Q3
798
138.34M
101.41%
-20.68M
2024Q2
800
136.29M
99.93%
-16.34M
2024Q1
799
135.97M
99.77%
-20.56M
2023Q4
809
135.31M
99.86%
-23.17M
2023Q3
797
133.80M
98.82%
-17.47M
2023Q2
837
137.28M
101.45%
-14.92M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
T. Rowe Price Associates, Inc.
14.43M
10.49%
+143.89K
+1.01%
Jun 30, 2025
The Vanguard Group, Inc.
13.96M
10.15%
+58.03K
+0.42%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.76M
8.55%
-46.83K
-0.40%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
7.51M
5.46%
+377.67K
+5.29%
Jun 30, 2025
State Street Investment Management (US)
7.34M
5.34%
+637.68K
+9.51%
Jun 30, 2025
Neuberger Berman, LLC
3.71M
2.7%
-88.92K
-2.34%
Jun 30, 2025
Cooke & Bieler, L.P.
3.30M
2.4%
-241.34K
-6.82%
Jun 30, 2025
Sound Shore Management, Inc.
3.29M
2.39%
+2.50K
+0.08%
Jun 30, 2025
Thompson, Siegel & Walmsley LLC
2.32M
1.69%
-189.94K
-7.55%
Jun 30, 2025
DePrince, Race & Zollo, Inc.
4.56M
3.32%
-7.61K
-0.17%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Sound Equity Dividend Income ETF
3.39%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
2.62%
Invesco Pharmaceuticals ETF
2.51%
SPDR S&P Pharmaceuticals ETF
2.42%
Invesco High Yield Equity Dividend Achievers ETF
1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.81%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
1.48%
Invesco S&P MidCap 400 Pure Value ETF
1.31%
Cultivar ETF
1.19%
iShares U.S. Pharmaceuticals ETF
1.13%
Ver más
Sound Equity Dividend Income ETF
Proporción3.39%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Proporción2.62%
Invesco Pharmaceuticals ETF
Proporción2.51%
SPDR S&P Pharmaceuticals ETF
Proporción2.42%
Invesco High Yield Equity Dividend Achievers ETF
Proporción1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción1.81%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
Proporción1.48%
Invesco S&P MidCap 400 Pure Value ETF
Proporción1.31%
Cultivar ETF
Proporción1.19%
iShares U.S. Pharmaceuticals ETF
Proporción1.13%
Dividendos
Un total de
698.10M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 19, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Mar 25, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 25, 2025
Mar 07, 2025
Nov 01, 2024
PRGO.NB Final Cash Dividend of gross USD 0.276 paid on Dec 17, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 17, 2024
Nov 29, 2024
Aug 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Sep 17, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 17, 2024
Aug 30, 2024
May 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Jun 18, 2024 going ex on May 31, 2024
May 31, 2024
Jun 18, 2024
May 31, 2024
Feb 26, 2024
PRGO.NB Interim Cash Dividend of gross USD 1.1 paid on Mar 26, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 26, 2024
Mar 07, 2024
Nov 03, 2023
PRGO.NB Final Cash Dividend of gross USD 0.273 paid on Dec 19, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 19, 2023
Nov 30, 2023
Aug 02, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Sep 19, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 19, 2023
Aug 31, 2023
May 04, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Jun 20, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jun 20, 2023
Jun 01, 2023
Feb 21, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Mar 28, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 28, 2023
Mar 09, 2023
Nov 04, 2022
PRGO.NB Final Cash Dividend of gross USD 0.26 paid on Dec 20, 2022 going ex on Dec 01, 2022
Dec 02, 2022
Dec 20, 2022
Dec 01, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Perrigo Company PLC?
Los cinco principales accionistas de Perrigo Company PLC son:
T. Rowe Price Associates, Inc. posee 14.43M acciones, lo que representa el 10.49% del total de acciones.
The Vanguard Group, Inc. posee 13.96M acciones, lo que representa el 10.15% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 11.76M acciones, lo que representa el 8.55% del total de acciones.
Dimensional Fund Advisors, L.P. posee 7.51M acciones, lo que representa el 5.46% del total de acciones.
State Street Investment Management (US) posee 7.34M acciones, lo que representa el 5.34% del total de acciones.
T. Rowe Price Associates, Inc. posee 14.43M acciones, lo que representa el 10.49% del total de acciones.
The Vanguard Group, Inc. posee 13.96M acciones, lo que representa el 10.15% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 11.76M acciones, lo que representa el 8.55% del total de acciones.
Dimensional Fund Advisors, L.P. posee 7.51M acciones, lo que representa el 5.46% del total de acciones.
State Street Investment Management (US) posee 7.34M acciones, lo que representa el 5.34% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Perrigo Company PLC?
Los tres principales tipos de accionista de Perrigo Company PLC son:
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
¿Cuántas instituciones poseen acciones de Perrigo Company PLC (PRGO)?
A fecha de 2025Q3, 771 instituciones poseen acciones de Perrigo Company PLC, con un valor de mercado combinado de aproximadamente 148.06M, lo que representa el 107.58% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 1.57%.
¿Cuál es la mayor fuente de ganancias de Perrigo Company PLC?
El FY2025Q2, el segmento empresarial Skincare and personal hygiene generó la ganancia más alta para Perrigo Company PLC, ascendiendo a 180.70M y representando el 17.11% de la ganancia total.
